P529 exposure–response relationship of vedolizumab subcutaneous treatment in patients with ulcerative colitis: VISIBLE 1

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
GiornaleJ Crohns Colitis
Year 2019
Loading references information
Questo articolo non ha abstract
Epistemonikos ID: ab6ba16700808d5c2b8c140a952cf3cc7c96e078
First added on: Dec 18, 2021